RE:WHERE DO WE GO FROM HEREIngiboy wrote: I think we all have to agree that this past few days have been big for Replicel. Despite the week starting with the news that the production of the first run of commercial Dermal Injectors will be delayed we have had some very encouraging news regarding Shiseido/RCH-01, 2 new patents in Japan and this last NR announcing the completion of the 2nd of 3 steps in achieving permission to start clinical trials in Japan.
For all the long suffering shareholders that have been with Replicel some for a short while and other for many years lets hope this is the beginning of a long run. There is no use speculating on where the share price will go, let's hope it is in an upward direction.
What we still don't know is when the Dermal Injector is ready for testing and CE Mark Approval.
Will Replicel and Shiseido settle their differences and collaborate on the next phase of developing RCH-01.
Once we get these questions answered we will be off to the races.
Sadly nothing has changed. Without a clear path to revenue replicel is dead. They still haven't addressed the trial results, and a tweet is not official.